Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Targeted siRNA Delivery and mRNA Knockdown Mediated by Bispecific Digoxigenin-binding Antibodies.

Schneider B, Grote M, John M, Haas A, Bramlage B, Ickenstein LM, Jahn-Hofmann K, Bauss F, Cheng W, Croasdale R, Daub K, Dill S, Hoffmann E, Lau W, Burtscher H, Ludtke JL, Metz S, Mundigl O, Neal ZC, Scheuer W, Stracke J, Herweijer H, Brinkmann U.

Mol Ther Nucleic Acids. 2012 Sep 18;1:e46. doi: 10.1038/mtna.2012.39.

2.

Error occurred: cannot get document summary

PMID:
28187849

3.

Bispecific digoxigenin-binding antibodies for targeted payload delivery.

Metz S, Haas AK, Daub K, Croasdale R, Stracke J, Lau W, Georges G, Josel HP, Dziadek S, Hopfner KP, Lammens A, Scheuer W, Hoffmann E, Mundigl O, Brinkmann U.

Proc Natl Acad Sci U S A. 2011 May 17;108(20):8194-9. doi: 10.1073/pnas.1018565108. Epub 2011 May 2.

4.

Hapten-Binding Bispecific Antibodies for the Targeted Delivery of SiRNA and SiRNA-Containing Nanoparticles.

Thorey IS, Grote M, Mayer K, Brinkmann U.

Methods Mol Biol. 2016;1364:219-34. doi: 10.1007/978-1-4939-3112-5_18.

PMID:
26472454
5.

Bispecific Antibodies for Targeted Delivery of Dendritic Polyglycerol (dPG) Prodrug Conjugates.

Mehrabadi FS, Adelmann J, Gupta S, Wedepohl S, Calderón M, Brinkmann U, Haag R.

Curr Cancer Drug Targets. 2016;16(7):639-49.

PMID:
26853135
6.

Delivery of the ribosome-inactivating protein, gelonin, to lymphoma cells via CD22 and CD38 using bispecific antibodies.

French RR, Penney CA, Browning AC, Stirpe F, George AJ, Glennie MJ.

Br J Cancer. 1995 May;71(5):986-94.

7.

Binary and ternary complexes based on polycaprolactone-graft-poly (N, N-dimethylaminoethyl methacrylate) for targeted siRNA delivery.

Huang Y, Lin D, Jiang Q, Zhang W, Guo S, Xiao P, Zheng S, Wang X, Chen H, Zhang HY, Deng L, Xing J, Du Q, Dong A, Liang Z.

Biomaterials. 2012 Jun;33(18):4653-64. doi: 10.1016/j.biomaterials.2012.02.052. Epub 2012 Apr 3.

PMID:
22480869
8.

MUC1-specific targeting immunotherapy with bispecific antibodies: inhibition of xenografted human bile duct carcinoma growth.

Katayose Y, Kudo T, Suzuki M, Shinoda M, Saijyo S, Sakurai N, Saeki H, Fukuhara K, Imai K, Matsuno S.

Cancer Res. 1996 Sep 15;56(18):4205-12.

9.

Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.

Beh CW, Seow WY, Wang Y, Zhang Y, Ong ZY, Ee PL, Yang YY.

Biomacromolecules. 2009 Jan 12;10(1):41-8. doi: 10.1021/bm801109g.

PMID:
19072631
10.
11.

Bispecific antibodies target operationally tumor-specific antigens in two leukemia relapse models.

Lindhofer H, Menzel H, Günther W, Hültner L, Thierfelder S.

Blood. 1996 Dec 15;88(12):4651-8.

12.

Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.

Gomes-da-Silva LC, Fonseca NA, Moura V, Pedroso de Lima MC, Simões S, Moreira JN.

Acc Chem Res. 2012 Jul 17;45(7):1163-71. doi: 10.1021/ar300048p. Epub 2012 May 8.

PMID:
22568781
13.

Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.

Günther M, Lipka J, Malek A, Gutsch D, Kreyling W, Aigner A.

Eur J Pharm Biopharm. 2011 Apr;77(3):438-49. doi: 10.1016/j.ejpb.2010.11.007. Epub 2010 Nov 18. Review.

PMID:
21093588
14.

A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.

Ding Y, Wang W, Feng M, Wang Y, Zhou J, Ding X, Zhou X, Liu C, Wang R, Zhang Q.

Biomaterials. 2012 Dec;33(34):8893-905. doi: 10.1016/j.biomaterials.2012.08.057. Epub 2012 Sep 12.

PMID:
22979990
15.

Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.

Yang XZ, Dou S, Sun TM, Mao CQ, Wang HX, Wang J.

J Control Release. 2011 Dec 10;156(2):203-11. doi: 10.1016/j.jconrel.2011.07.035. Epub 2011 Aug 1.

PMID:
21839126
16.

Nonviral pulmonary delivery of siRNA.

Merkel OM, Kissel T.

Acc Chem Res. 2012 Jul 17;45(7):961-70. doi: 10.1021/ar200110p. Epub 2011 Sep 9.

PMID:
21905687
17.

A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy.

Mao CQ, Du JZ, Sun TM, Yao YD, Zhang PZ, Song EW, Wang J.

Biomaterials. 2011 Apr;32(11):3124-33. doi: 10.1016/j.biomaterials.2011.01.006. Epub 2011 Jan 28.

PMID:
21277018
18.

Isolation and characterization of an anti-CD16 single-chain Fv fragment and construction of an anti-HER2/neu/anti-CD16 bispecific scFv that triggers CD16-dependent tumor cytolysis.

McCall AM, Adams GP, Amoroso AR, Nielsen UB, Zhang L, Horak E, Simmons H, Schier R, Marks JD, Weiner LM.

Mol Immunol. 1999 May;36(7):433-45.

PMID:
10449096
19.

Cooperative mixtures of bispecific F(ab')2 antibodies for delivering saporin to lymphoma in vitro and in vivo.

French RR, Courtenay AE, Ingamells S, Stevenson GT, Glennie MJ.

Cancer Res. 1991 May 1;51(9):2353-61.

20.

Intracellular Delivery of Short Interfering RNA in Rat Organ of Corti Using a Cell-penetrating Peptide PepFect6.

Dash-Wagh S, Jacob S, Lindberg S, Fridberger A, Langel U, Ulfendahl M.

Mol Ther Nucleic Acids. 2012 Dec 11;1:e61. doi: 10.1038/mtna.2012.50.

Supplemental Content

Support Center